Physician profile
Akash Deep Agarwal
NPI 1073622346
$25,627.96
in general payments reported to CMS, 2019-2025
12 companies · $8,465 in 2025
The $8,465 reported for 2025 was more than what 84% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $533 · 2020: $193 · 2021: $626 · 2022: $128 · 2023: $8,928 · 2024: $6,755 · 2025: $8,465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Food and Beverage: $2,838 · Travel and Lodging: $2,115 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,175.00 |
| Food and Beverage | $2,838.05 |
| Travel and Lodging | $2,115.04 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $20,804.65 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Osteocool Rf Ablation System |
| Boston Scientific Corporation | $3,538.71 | 2024-2025 | Intracept, Intracept Rf Probe, Clinical Trial Product |
| Medtronic USA, INC. | $487.65 | 2019-2020 | |
| Amgen INC. | $399.91 | 2019-2024 | |
| Stryker Corporation | $190.28 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $64.99 | 2020-2022 | |
| Cerapedics INC. | $47.07 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Zimmer Biomet Holdings, INC. | $26.49 | 2020 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Eisai INC. | $19.73 | 2022 | |
| Depuy Synthes Sales INC. | $14.48 | 2022 | |
| Ceribell, INC. | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akash Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.